Dapagliflozin Impurity 9 is a pharmaceutical impurity reference standard. It is a stereochemically defined compound containing multiple hydroxyl groups, aromatic rings, and an ether functionality, used in quality control and manufacturing processes for dapagliflozin-related products.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1469910-70-0
Tert-butyl N-(chlorosulfonyl)carbamate
pharmaceutical intermediate
(1R,2S,5R)-Menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid
pharmaceutical intermediate
(S)-4-N-Boc-2-methylpiperazine
pharmaceutical intermediate
(S)-(-)-1-Boc-3-aminopyrrolidine
pharmaceutical intermediate
(2S,3R,4R,5S)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-[(1S)-1,2-dihydroxyethyl]oxolane-3,4-diol
RRYZEJFQBYDTNH-ZPAWYTMASA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H](O3)[C@H](CO)O)O)O)Cl